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Abstract.  NAFLD, liver component of the “metabolic” syndrome, has become the most common liver disease in 
western nations. Non-invasive imaging techniques exist, but have limitations, especially in detection and quantification 
of mild to moderate fatty liver. In this pilot study, we produced attenuation curves from biomedical-quality projection 
images of liver and fat using the MARS spectroscopic-CT scanner. Difficulties obtaining attenuation spectra after 
reconstruction demonstrated that standard reconstruction programs do not preserve spectral information.  
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INTRODUCTION 
We aim to demonstrate the potential of a novel 
spectroscopic-CT scanner to improve the evaluation of 
non-alcoholic fatty liver disease (NAFLD). NAFLD 
has become the most common form of liver disease in 
Western communities, affecting an estimated 17-33% 
of American adults (1). Primary NAFLD is the liver 
component of the “metabolic syndrome”, a collection 
of diseases associated with obesity (2). The clinical 
spectrum of NAFLD ranges from simple fatty liver or 
steatosis, to non-alcoholic steatohepatitis (NASH, fatty 
liver with inflammation and evidence of hepatocyte 
damage), cirrhosis, and hepatocellular carcinoma or 
liver failure (1). In this pilot study, we demonstrate a 
method for measuring the attenuation curves of liver 
and fat tissue on a 3D X-ray imaging device with the 
anatomical resolution of a typical small animal micro-
CT and with anticipated practical applications towards 
the quantification of fat in the liver.   
NAFLD is traditionally diagnosed by invasive liver 
biopsy, with findings of macro-vesicular fat (2). Non-
invasive techniques are available, all with limitations, 
including ultrasonography (US), computed 
tomography (CT), dual energy CT, and magnetic 
resonance imaging (MRI) (3). Using US, only 
moderately severe fatty liver (greater than 30%) can be 
detected, and fat content cannot be quantified (2). On 
CT, fatty liver has a decreased attenuation compared to 
normal liver, and a threshold value of 10 HU below 
the spleen is used to qualitatively diagnose fatty liver. 
However, this criteria is not quantitative and is not 
sensitive to mild or moderate (5-30%) fatty liver (2,3). 
MRI is currently the most sensitive technique: fat can 
be detected and quantified using a T1-weighted 
gradient-echo in/out of phase sequence (3), but MRI is 
more expensive and less readily available than CT.   
 Dual energy CT has shown promise at beginning 
to address the sensitivity and quantification issues 
associated with single energy CT (4). A significant 
difference in attenuation between high and low X-ray 
tube voltage (∆H) is seen for fatty liver but not for 
normal liver, and ∆H is linearly correlated with 
percent fat (determined by histology) in rabbits (5) and 
humans (4). Dual-CT has been used to screen potential 
liver donors for fatty infiltration (6), however liver 
iron overload interferes with this measurement (4,7). 
Since dual-CT has shown that energy information is 
valuable in diagnosing fatty liver, it is anticipated that 
spectroscopic-(multi-energy)-CT will improve our 
ability to quantify fat. The first step in investigating 
this would be to demonstrate the ability to extract the 
attenuation spectra of fat and liver from spectroscopic-
CT images.   
X-ray attenuation curves have been measured for a 
variety of elements, compounds and mixtures, 
including adipose tissue, and are well understood (8). 
These curves are traditionally measured on a 
spectroscope, by scanning a monochromatic X-ray 
beam from a monochromator through a range of 
energies and measuring the absorption across that 
range. However, unless an expensive synchrotron X-
ray source is used, the beams are not intense enough to 
provide the spatial information required for biological 
imaging. The aim of this study is to produce 
attenuation curves from biomedical quality images of 
fat and liver tissues using the Medipix-2 spectroscopic 
detector in the MARS-CT scanner.  
METHODS 
CT-Scan and Reconstruction 
Sheep liver and fat samples were prepared for 
scanning as follows: intact tissue was cut into 
cylindrical slices and packed tightly into a 25 cc 
syringe. For the 50/50 liver/fat tissue blend, equal 
weights of each tissue were blended until homogenous, 
and the resulting paste was carefully piped into a 25 cc 
syringe. All syringes of tissue were loaded into a 
perspex tube and scanned using the energy-sensitive 
photon counting pixel detector, Medipix-2 (pixel 
dimensions 55x55 µm2, detector size 14x14 
mm2), taking 303 projections at 5 vertical detector 
positions and using each of the following 7 low energy 
thresholds: 12.5 keV, 15 keV, 17.5 keV, 20 keV, 25 
keV, 30 keV, 35 keV. Acquisition times for each 
energy threshold were adjusted to give photon counts 
of approximately 1000.  
The reconstructions were performed with Octopus 
version 8.2. (9). Projection data was spot filtered 
(using the Octopus "normal (10)" setting) and 
transformed using cone beam reconstruction with 
linear interpolation and a regular Fourier filter. 
Reconstructions used a source detector distance (SDD) 
of 125 mm, a source object distance (SOD) of 85 mm, 
a centre of rotation of 759 pixels, and a vertical centre 
of 270 pixels.  
Constructing Attenuation Curves 
For ten projections of each sample at each of the 
seven low energy thresholds, the images were 
normalized by the acquisition time to obtain images in 
terms of photon counts per second. To obtain energy 
bins, the images for higher low energy thresholds were 
subtracted from the image for the low energy threshold 
directly below. On the subtracted images, a region of 
interest (ROI) corresponding to the tissue and to air 
(the open beam value) was selected and the average 
intensity taken. The tissue values were normalized by 
the air values and the negative logarithm was taken to 
get absorbance values. Finally, these values were 
divided by the average length of tissue the x-rays went 
through to get linear attenuation. Error was propagated 
from the standard deviation of the ROI using standard 
methods for all ten projections and combined to get an 
estimate of the natural variation of the tissue. The 
standard deviation of the calculated attenuation values 
across the ten projections (independent measurements) 
was taken as an estimate of the error in measurement. 
RESULTS AND DISCUSSION 
Attenuation Curves from Spectroscopic-
CT Projection Images  
To determine if attenuation spectra can be 
extracted from CT images, we performed a pilot study 
with sheep liver and fat. Liver, fat and a 50/50 weight 
to weight blend were scanned using seven different 
low energy thresholds. For ten projections of each 
sample, the images for different thresholds were 
subtracted to obtain images for energy bins. ROI’s 
corresponding to the tissue and to air (the open beam 
value) were selected and average photon counts taken. 
From these values, linear attenuation was calculated. 
Here for the first time, we were able to construct linear 
attenuation curves directly from projection images 
taken on a CT scanner (Figure 1). 
The data shows that the difference in linear 
attenuation between fat and liver is quite large, due to 
the difference in density of the tissues. However over 
this energy range the spectra themselves are not 
largely different by inspection. If we compare the ratio 
of attenuation values for fat and liver over the energy 
range we have measured, the attenuation of liver is 
always roughly twice that of fat. This is shown in 
Figure 1 by aiding comparison of the two curves using 
a constant scaling factor. This does not preclude 
significant differences between the spectra over the 10 
keV to 100 keV range. From the dual CT studies we 
know fat and liver differ at the higher energy end of 
the spectrum (5), and theoretically also at the lower 
energies where the k-edges of biological elements lie.  
The estimated error in our measurement of linear 
attenuation (as measured over ten projection images, 
represented by the smaller error bars) does not impede 
distinction between liver and fat at any particular 
energy bin, and neither does the estimated variation in 
the actual tissue itself, (as measured by the variation in 
intensity over about 1000 pixels of the tissue, 
represented by the larger error bars). The difference in 
linear attenuation between fat and liver at low energy 
bins is quite large and it is linear attenuation that is 
represented on CT slices. In addition the liver/fat blend 
shows an intermediate difference in linear attenuation. 
While the curve for the 50/50 blend is more similar to 
fat than liver, this is due to the greater volume of fat 
when a weight to weight (w/w) ratio is used. This 
study indicates quantitative information can be 
obtained by the use of narrow energy bins at low 
energies, as opposed to traditional broad spectrum CT. 
We have not addressed however in this pilot study the 
impact of variation from individual to individual, or 
variation over different types of fat deposits.  
 
 
 
 
FIGURE 1.  Construction of Liver, Fat and Liver/Fat Blend Linear Attenuation Curves from CT Images. A. Raw CT projection 
images of the three tissue preparations at 15 keV. B. Images reconstructed from 303 projections at 15 keV. C. Linear attenuation 
curves built from the projection images. Estimated error in measurement is shown by the smaller error bars, and estimated 
variation in the tissue is shown with the larger error bars. 
 
To our knowledge, this is the first time attenuation 
curves have been constructed from biomedical-quality 
images. We have demonstrated that energy 
information, which can aid in distinguishing soft 
tissues such as liver and fat, can be extracted from 
projection images. Thus far, we have been unable to 
obtain accurate data from the reconstructed images 
with available cone beam reconstruction algorithms. 
There are likely several reasons for this. For one, the 
software used requires that images are converted in 
and out of various formats multiple times during the 
reconstruction and image processing. Preserving the 
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spectral information contained in the images is 
difficult as the individual data sets are rescaled during 
these conversions. Simulations have indicated that 
multiple energy CT reconstructions can benefit from 
modified weightings during back projection (10) and 
other adaptations to traditional reconstruction 
techniques. Our future work in reconstruction will 
continue towards preserving spectral information for 
each and every voxel. 
By demonstrating that we are able to measure fat 
and liver spectra with a small error in measurement, 
this pilot study establishes the potential to investigate 
differences in the spectra at alternative energy ranges 
with the MARS-CT scanner.  
Composition Analysis 
One proposed method of quantifying materials 
based on their spectral differences makes use of 
Principle Component Analysis (PCA) (11) and the 
Mahalanobis distance (12). For example, by 
conducting PCA on a sample of liver in multiple 
dimensions defined by attenuation over an energy 
range in which spectral differences from fat exist, we 
define the directions and magnitudes of maximum 
variance. This defines a region (in our multi-
dimensional attenuation space) considered to be liver. 
Repeating this on a sample of fat, we can obtain a 
similar region considered to be fat. It is proposed that 
the Mahalanobis distance can then be used to quantify 
the likely ratio of fat and liver in any particular voxel. 
The magnitude of the Mahalanobis distance of the 
voxel data to either the liver or the fat regions gives a 
measure of likelihood that the voxel is fat and/or liver 
while the ratio of the Mahalanobis distances gives the 
ratio of fat to liver. There are also other methods 
currently being investigated for component analysis 
from spectral CT data. (13). 
CONCLUSIONS 
We have demonstrated the ability to 
simultaneously obtain spectral and biomedical-quality 
imaging information using the MARS-CT scanner. 
From projection images of liver, fat and a 50/50 
blend, we were able to construct linear attenuation 
curves with a relatively small error in measurement.  
 Currently the spectral information is obtained from 
raw projection images, but by improving the software 
algorithms and data processing techniques the same 
information could be obtained from voxel data after 
reconstruction. This will allow spectral imaging of 
more complicated structures and for analysis of voxels 
based on spectral information by PCA. Further testing 
and exploration using the Mahalanobis distance and 
different energy ranges could lead to a method 
for quantifying fat/liver ratios based on their spectral 
differences. In addition it is worth investigating the use 
of the large difference in linear attenuation between 
liver and fat, enhanced by using low energy ranges and 
discrete energy bins.  
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